NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week, the KPHC rose 2%, while the Danish
In the past week, the Power2X & Fuel Cells sector skyrocketed with a 23% increase on a sector level. Many companies in the sector did
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week, six companies reported financial results, Ascendis Pharma
In the past week, the Mobility and Energy Production & Storage sectors did very well – again. The best-performing stock is about to be acquired
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week, Gubra increased their financial outlook for 2024,
In the past week, the Mobility and Energy Production & Storage sectors did very well. The best-performing stocks were driven by Q1 results, a collaboration
In the past week, the Power2X & Fuel Cells and Waste Management sectors did very well. A license to a 2.5 GW offshore wind project,
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week, Genmab and Zealand Pharma received new price
In the past week, the Energy Production & Storage sector did well although it was driven by a few stocks with great performance. Only a
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week was full of exciting news. Genmab announced
Kapital Partner A/S
Christian IX's Gade 10, 4. th
1111 København K
CVR: 37364843
Kapital Partner udfører eller har inden for de seneste 12 måneder udført corporate finance, market relations, investor relations, Certified Adviser eller andre rådgivningsaktiviteter for følgende børsnoterede selskaber: CS Medica, EKOBOT AB, Biotech, Ensurge, Lifecare AS, NORD.investments, Biosergen, Hypefactors, Curasight, Re-Match, Mdundo.com, Nexcom.
Del indlægget på sociale media eller på email.